From AHLA's Health Law Weekly: Compass Pathways' February 2026 announcement of successful Phase 3 results for COMP360 psilocybin in treatment-resistant depression, with an expected Q4 2026 new drug application submission, brings psychedelic therapy to ...

From AHLA's Hospitals and Health Systems Practice Group: This Toolkit is designed to provide relevant resources related to the fair market value and commercial reasonableness of hospital-physician arrangements in a central location. The Toolkit is structured ...